18F-PF-06445974 | Interleukin Related interleukin-related.com

Product Name :
18F-PF-06445974

Search keywords :
PF-06445974

drugId :
null

Target Vo:
Phosphodiesterase 4B

Target Vo Short Name :
PDE4B

Moa_Name:
Phosphodiesterase 4B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
National Institute Of Mental Health (Nimh)

Active Indication_Name:
Depression

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Satralizumab manufacturer
Ret Rabbit mAb Technical Information
CD86 Antibody: CD86 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 38 kDa, targeting to CD86. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts